文献速递头颈外科

Ⅱ期口腔舌癌:基于浸润深度的辅助放疗生存影响

Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-06-26

本研究利用美国国家癌症数据库回顾性分析2004—2013年934例pN0期(pT2N0)口腔舌癌且手术切缘阴性患者,比较单纯手术与手术联合术后放疗的生存差异。

要点

  • pT2N0口腔舌癌切缘阴性者,术后放疗未显示总生存获益
  • 浸润深度>5 mm亚组同样无生存获益(HR=0.93,95%CI 0.57-1.53)

核心结论

  • 对于pT2N0口腔舌癌且手术切缘阴性的患者,术后放疗相较单纯手术未显示总生存获益,且与肿瘤浸润深度无关。

研究设计与样本

  • 回顾性队列研究,数据来自美国国家癌症数据库(National Cancer Database)。
  • 纳入2004—2013年诊断为pT2N0口腔舌癌且手术切缘阴性的病例,共934例。
  • 按治疗方式分层为单纯手术组与手术+术后放疗组,后者占27.5%(n=257)。
  • 单因素分析采用两样本t检验、卡方检验或Fisher精确检验及log-rank检验。
  • 多因素分析采用Cox回归模型,并对各变量及倾向性评分进行调整。

临床怎么用

  • 对于pT2N0、切缘阴性的口腔舌癌,辅助放疗不应仅基于分期或浸润深度>5 mm而常规推荐,需结合其他高危因素个体化决策。

局限性

  • 为回顾性数据库研究,存在选择偏倚可能,作者采用倾向性评分校正。
  • 研究仅评估总生存,未报告无病生存或局部控制等终点。
  • 术后放疗组仅占27.5%,样本分布不均衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if adjuvant radiation therapy for patients with pT2N0 oral cavity tongue cancer affects overall survival. STUDY DESIGN: Retrospective cohort study. SETTING: National Cancer Database. SUBJECTS AND METHODS: Cases diagnosed between 2004 and 2013 with pathologic stage pT2N0 oral cavity tongue cancer with negative surgical margins were extracted from the National Cancer Database. Data were stratified by treatment received, including surgery only and surgery + postoperative radiation therapy. Univariate analysis was performed with a 2-sample t test, chi-square test, or Fisher exact test and log-rank test, while multivariate analysis was performed with Cox regression models adjusted for individual variables as well as a propensity score. RESULTS: A total of 934 patients were included in the study, with 27.5% of patients receiving surgery with postoperative radiation therapy (n = 257). In univariate analysis, there was no significant difference in 3-year overall survival between the patient groups ( P = .473). In multivariate analysis, there was no significant difference in survival between the treatment groups, with adjuvant radiation therapy having a hazard ratio of 0.93 (95% CI, 0.60-1.44; P = .748). Regarding tumors with a depth of invasion >5 mm, there was no survival benefit for the patients who received postoperative radiation therapy as compared with those who received surgery alone (hazard ratio = 0.93; 95% CI, 0.57-1.53; P = .769). CONCLUSION: An overall survival benefit was not demonstrated for patients who received postoperative radiation therapy versus surgery alone for pT2N0 oral cavity tongue cancer, irrespective of depth of tumor invasion.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Rubin SJ, Gurary EB, Qureshi MM, et al. Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion. Otolaryngol Head Neck Surg. 2018. PMID: 29944460. doi:10.1177/0194599818779907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。